GlassScriptPhysician profile
Matthew A Janiga
NPI 1891912259
$2,215.74
in general payments reported to CMS, 2019-2025
19 companies · $634 in 2025
The $634 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $406 · 2021: $699 · 2022: $263 · 2023: $99.00 · 2024: $114 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656 · Education: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.29 |
| Education | $191.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $900.13 | 2021-2022 | |
| Neotract INC. | $385.93 | 2020 | |
| Astellas Pharma US INC | $211.24 | 2020-2025 | |
| Calyxo, INC. | $179.37 | 2025 | Cvac Aspiration System |
| Valencia Technologies Corporation | $73.13 | 2024-2025 | Ecoin Device Kit |
| Teleflex LLC | $66.23 | 2022-2025 | Barrigel |
| Procept Biorobotics Corporation | $66.09 | 2024-2025 | Aquabeam System |
| Urogen Pharma, INC. | $59.69 | 2025 | |
| Pfizer INC. | $43.61 | 2025 | |
| Endo USA, INC. | $34.69 | 2024-2025 | Xiaflex |
| C. R. Bard, INC. & Subsidiaries | $31.93 | 2025 | Bard Urinary Drainage Bag |
| Novartis Pharmaceuticals Corporation | $28.34 | 2025 | |
| Angiodynamics, INC. | $27.49 | 2025 | Nanoknife |
| Progenics Pharmaceuticals, INC. | $22.48 | 2025 | |
| Allergan, INC. | $21.78 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18.04 | 2025 | General - Kidney Stone Disease |
| Abbvie INC. | $16.82 | 2025 | |
| Convatec INC. | $14.61 | 2024 | |
| Acerus Pharmaceuticals Corporation | $14.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Janiga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.